drugset / Trial / NCT02755389

Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow

NCT02755389

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized clinical trial investigating the utility of apneic oxygenation via nasal cannulae in the post-induction setting for the purpose of prolonging the safe apneic time. Three groups will be compared, a control group at 0 L/min, a 15 L/min and a 60 L/min group. The primary outcome will be the difference in the partial pressure of oxygen in arterial blood (PaO2) between groups throughout the nine-minute apneic period.

Timeline

Start
2016-09
Primary completion
2018-06-22
Completion
2018-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 15 unknown Intranasal
Subject Oxygen Other / unclassified 60 unknown Intranasal

Indications

No indication recorded.